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INTRODUCTION
Current evidence indicates that chronic subclinical inflam-
mation may play an important role in the genesis and pro-
gression of atherosclerosis, and many recent reports have ex-
plored the association between C-reactive protein (CRP) lev-
els and atherosclerosis. CRP is present in the acute reaction
phase of inflammation, and elevated levels of serum CRP
are related to a poorer outcome in patients with cardiovas-
cular diseases (1, 2).
Several studies have suggested that CRP is a predictor of
subsequent cardiovascular events in healthy adults (3). Recen-
tly, high-sensitivity C-reactive protein (hs-CRP) has emerged
as a useful biomarker for vascular inflammation associated
with atherosclerosis. While a significant amount of data has
been amassed about vascular disease in adults, limited data
exists concerning the low grade inflammation in obese chil-
dren. Because atherosclerosis frequently begins in childhood,
we assessed the association of two markers of early atheroscle-
rosis, serum hs-CRP level and atherosclerotic risk factors
with carotid intima-media wall thickness (IMT) and brachial
flow-mediated dilation (FMD) in obese children.
MATERIALS AND METHODS
Subjects
The study subjects were 83 children. Thirty-eight children
were obese (14-16 yr of age, male), and 45 were sex/age-ma-
tched healthy control children. All were nonsmokers with-
out any regular medication and had no family history of pre-
mature vascular disease. None of the children had symptoms
of infection during the 2 weeks before the study.
Anthropometric measurement and clinical examination
Body height and weight were measured in light clothes
using a portable standiometer. Body mass index (BMI) was
calculated as weight divided by the square of the height (kg/
m2). In children, the 95th percentile for BMI in the 2000
CDC growth chart is 21-23 (4), so we used BMI >23 as our
prospectively defined criterion for obesity, and BMI <21 was
defined as the non-obese control level.
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A Useful Predictor of Early Atherosclerosis in Obese Children: Serum
High-sensitivity C-reactive Protein 
Childhood obesity seems to contribute to the development of vascular inflammation
and the progression of arterial wall changes. High-sensitivity C-reactive protein (hs-
CRP) has recently emerged as a useful biomarker for vascular inflammation asso-
ciated with atherosclerosis. The objectives of this study were to evaluate the asso-
ciation of the serum hs-CRP level with ultrasonic findings of early atherosclerosis,
carotid intima-media wall thickness (IMT) and brachial flow-mediated dilation (FMD),
in obese children. Thirty eight obese children and 45 sex/age-matched healthy con-
trol children were recruited. Serum CRP levels were measured by the high-sensi-
tive latex turbidimetric immunoassay, and we measured carotid IMT and brachial
FMD using high-resolution B-mode ultrasonography. Obese children had signifi-
cantly higher hs-CRP levels (1.40± ±0.74 mg/L vs. 0.55± ±0.49 mg/L, p<0.01), as
well as increased IMT (0.52± ±0.09 mm vs. 0.41± ±0.07 mm, p<0.01) and impaired
FMD (7.35± ±7.78% vs. 20.34± ±16.81%, p<0.01) compared to healthy controls.
Serum hs-CRP correlated positively with IMT (r=0.413, p<0.05) and inversely with
FMD (r=-0.350, p<0.05) in the obesity group. Measurement of the serum hs-CRP
level is a simple, cheap, and highly reproducible assay and correlates with IMT and
FMD in obese children. Thus, it would be a useful marker for evaluating and esti-
mating the degree of atherosclerosis in children. 
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Serum lipids and apolipoprotein
Venous blood samples were taken in the morning after
overnight fasting (10-12 hr). Serum total cholesterol (TC),
low density lipoprotein cholesterol (LDL-C), high density
lipoprotein cholesterol (HDL-C), and triglyceride (TG) con-
centrations were measured by standard enzymatic methods
with the use of Boehringer Mannheim GmbH and a fully
automatic analyzer. Serum apolipoprotein A-1 (Apo A-1),
apolipoprotein B (Apo B), and apolipoprotein E (Apo E) were
measured by immunonephelometry (Behring Nephelome-
ter II, Dade Behring, Inc., Newark, DE, U.S.A.).
High-sensitivity C-reactive protein
A BN II Nephelometer Analyzer (Dade Behring, Inc.) was
used to measure serum hs-CRP values using a high sensitiv-
ity latex-enhanced immunonephelometric assay method. The
detection limit of this assay was 0.17 mg/dL. Because the
90th percentile of normal CRP distribution is 0.3 mg/dL,
we included only patients with CRP values below 0.3 mg/
dL to avoid the influence of acute infection.
Ultrasound studies
All ultrasound studies were performed in the morning on
fasting subjects with the use of Hewlett-Packard Sonos 5500
and a 3-11 MHz linear array transducer (Philips, Andover,
Massachusetts, U.S.A.). All ultrasound scans were performed
by an experienced vascular operator who was unaware of the
children’s clinical details. Blood pressure was measured from
the brachial artery of the nondominant arm 3 times during
the ultrasound study with the use of a standard sphygmo-
manometer, and the mean value of these 3 measurements
was used for the analyses. The brachial artery evaluations and
carotid artery evaluations were performed by using standard
techniques for the study of children.
Brachial artery evaluation
Brachial artery diameter was measured during reactive
hyperemia from B-mode ultrasound images at rest. The sub-
jects lay quietly for 10 min before the first scan. The brachial
artery was scanned in a longitudinal section 5 to 15 cm above
the elbow. Depth and gain settings were set to optimize ima-
ges of the lumen-arterial wall interface, and the operating
parameters were kept constant during the study. A resting
scan was performed, and the arterial flow velocity was mea-
sured using a Doppler signal. Increased flow was then induced
by inflation of a pneumatic tourniquet placed around the
forearm (distal to the scanned part of the artery) to a pressure
of 250 mmHg for 5 min, followed by release. Subsequent
scans were taken continuously for 60 sec after cuff deflation.
We also included a repeated flow velocity recording for the
first 15 sec after the cuff was released. Vessel diameter was
measured by an experienced reader who were blind to the
study subjects’ laboratory data. The arterial diameter was
measured at a fixed distance from an anatomic marker with
the use of ultrasonic calipers. Measurements were taken from
the anterior to the posterior M line at end diastole, incident
with the R wave on a continuously recorded ECG. The maxi-
mal proportional dilatation from baseline (FMD) was assessed.
Carotid artery analysis
Carotid artery IMT measurements were done according
to a predetermined, standardized scanning protocol for the
right carotid artery. Briefly, the proximal part of the carotid
bulb was identified and the segments of the common carotid
arteries 1 to 2 cm proximal to the bulb were scanned. The
image was focused on the posterior wall, and the resolution
box function was used to magnify the arterial far wall. All
scans were digitally stored for subsequent offline analysis.
One end-diastolic frame (captured adjacent to the R wave on
a continuously recorded ECG) for each interrogation angle
was selected and analysed for mean IMT. Five measurements
for far wall IMT were taken manually for each image using
ultrasonic calipers, and the average values of these readings
were used for the analyses.
Statistical analyses
SPSS version 11.0 was used for all statistical calculations.
Results were expressed as mean±standard deviation. Com-
parisons between two groups were performed by the inde-
pendent student-t test. Univariate and multivariate regres-
sion analyses were used to dclineate the relationships between
arterial changes and CRP. Due to the skewed distribution of
hs-CRP levels, CRP values were logarithmically transformed
prior to regression analyses. For all analyses, probability (p)
values below 0.05 were considered statistically significant.
RESULTS
Clinical characteristics
Height and weight were significantly higher in the obesity
group than in the control group. BMI was 29.40±3.18 kg/
m2 in the obesity group and was 18.43±1.00 kg/m2 in the
control group (Table 1). Obese children had significantly
higher systolic blood pressure (SBP) (133.05±8.84 mmHg
vs. 115.16±8.62 mmHg), diastolic blood pressure (DBP)
(84.95±9.02 mmHg vs. 75.16±6.92 mmHg), hs-CRP
levels (0.10±0.07 mg/dL vs. 0.06±0.04 mg/dL, p<0.01)
and significantly higher LDL-C, TG, Apo B and lower HDL-
C than the control group (Table 2). TC and Apo E were higher
and Apo A-1 was lower in the obesity group than in the con-
trol group, but these differences were not statistically signif-
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Ultrasonic findings
Obese children were also found to have increased IMT (0.52
±0.09 mm vs. 0.40±0.07 mm, p<0.001) and impaired
FMD (7.35±7.78% vs. 20.34±16.81%, p<0.001) com-
pared to healthy controls (Table 3). 
Relationships between IMT, FMD and atherosclerotic risk
factors
IMT correlated with BMI (r=0.612, p<0.001), SBP (r=
0.510, p<0.001), DBP (r=0.307, p<0.05), and HDL-C (r=
-0.221, p<0.05). FMD correlated with BMI (r=-0.414, p<
0.001), SBP (r=-0.437, p<0.001), TG (r=-0.445, p<0.05),
and Apo E (r=-0.402, p<0.05) (Table 4).
Relationships between hs-CRP and atherosclerotic risk
factors
Log [CRP] showed a positive correlation with BMI (r=
0.470, p<0.001), SBP (r=0.209, p<0.05), DBP (r=0.230,
p<0.05), Apo E (r=0.308, p<0.01), and TG (r=0.288, p<
0.05) by simple regression (Table 5).
Relationships between hs-CRP and ultrasonic findings
Serum hs-CRP correlated positively with IMT (r=0.413,
p<0.05) and inversely with FMD (r=-0.350, p<0.05) in the
obesity group (Fig. 1, 2).
Values are mean±standard deviation.
BMI, body mass index; BP, blood pressure; p, p-value. 
Obesity (n=38) Control (n=45) p
Age (yr) 14.76±0.8 14.00±0.00 NS 
Height (cm) 164.47±9.0 155.14±7.34 <0.01
Weight (kg) 80.05±13.30 44.53±5.13 <0.01
BMI (kg/m
2) 29.40±3.18 18.43±1.00 <0.01
Systolic BP (mmHg) 133.05±8.84 115.16±8.62 <0.01
Diastolic BP (mmHg) 84.95±9.02 75.16±6.92 <0.01
Table 1. Comparison of characteristics between obesity and
control groups 
Values are mean±standard deviation.
IMT, intima-media thickness; FMD, flow-mediated dilation; p, p-value. 
Obesity (n=38) Control (n=45) p
IMT (mm) 0.52±0.09 0.41±0.07 <0.01
FMD (%) 7.35±7.78 20.34±16.81 <0.01
Table 3. Comparison of ultrasonic findings between obesity and
control groups 
IMT, intima-media thickness; FMD, flow-mediated dilation; BMI, body
mass index; SBP, systolic blood pressure; DBP, diastolic blood pres-
sure; PP, pulse pressure; TC, total cholesterol; LDL-C, low density lipop-
rotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyc-
eride; Apo A-1, apolipoprotein A-1; Apo B, apolipoprotein B; Apo E, apo-
lipoprotein E; r, correlation coefficient; p, p-value. 
IMT
r p
Variables
FMD
r p
BMI 0.612 <0.001 -0.414 <0.001
SBP 0.510 <0.001 -0.437 <0.001
DBP 0.307 <0.01 -0.194 NS
TC -0.263 NS -0.220 NS
LDL-C -0.163 NS -0.223 NS
HDL-C -0.221 <0.05 0.142 NS
TG -0.028 NS -0.445 <0.01
Apo A-1 -0.135 NS 0.026 NS
Apo B -0.092 NS -0.150 NS
Apo E 0.021 NS -0.402 <0.05
Table 4. Correlation of IMT and FMD with BMI, BP, lipid profile,
and apolipoprotein concentrations
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic
blood pressure; PP, pulse pressure; TC, total cholesterol; LDL-C, low
density lipoprotein cholesterol; HDL-C, high density lipoprotein choles-
terol; TG, triglyceride; Apo A-1, apolipoprotein A-1; Apo B, apolipopro-
tein B; Apo E, apolipoprotein E; r, correlation coefficient; p, p-value. 
hs-CRP
r p
Variables
BMI 0.470 <0.001
SBP 0.209 <0.05
DBP 0.230 <0.05
TC 0.094 NS
LDL-C 0.104 NS
HDL-C -0.123 NS
TG 0.308 <0.01
Apo A-1 -0.182 NS
Apo B 0.017 NS
Apo E 0.288 <0.01
Table 5. Correlation of log hs-CRP with BMI, BP, lipid profile, and
apolipoprotein concentrations
Values are mean±standard deviation.
TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C,
high density lipoprotein cholesterol; TG, triglyceride; Apo A-1, apolipop-
rotein A-1; Apo B, apolipoprotein B; Apo E, apolipoprotein E, hs-CRP;
high-sensitivity C-reactive protein; p, p-value.
Obesity (n=38)
Metabolic 
parameters
Control (n=45) p
TC (mg/dL) 193.46±38.20 180.38±39.84 NS
HDL-C (mg/dL) 63.20±15.92 72.58±17.06 <0.05
LDL-C (mg/dL) 114.09±29.90 99.71±29.91 <0.05
TG (mg/dL) 148.63±78.83 96.49±54.97 <0.01
Apo A1 (mg/dL) 74.17±34.88 78.76±36.66 NS
Apo B (mg/dL) 37.89±20.0 30.00±12.38 <0.05
Apo E (mg/dL) 3.54±1.31 3.42±1.71 NS
hs-CRP (mg/L) 1.40±0.74 0.55±0.49 <0.01
Table 2. Comparison of metabolic parameters between obesity
and control groups A Useful Predictor of Early Atherosclerosis in Obese Children 195
DISCUSSION
The present study showed that elevated serum CRP levels
were significantly associated with endothelial dysfunction
and increased carotid artery IMT in obese children. While
there have been many previous studies relating CRP and
cardiovascular risk factors (5, 6), the association of CRP with
subclinical atherosclerotic findings has been examined pri-
marily in adults, with few studies in obese children (7, 8).
Historically, CRP has been measured in clinical laborato-
ries by immunoturbidimetric and immunonephelometric
assays designed to detect active inflammation and infection.
The dynamic range of these assays is from 3 mg/L (90th per-
centile of the general population) to well over 200 mg/L. Al-
though such assays are automated and reproducible, they have
a relatively low detection limit of 3 to 8 mg/L and thus do
not have appropriate sensitivity in the range required for the
determination of cardiovascular risk (9). To achieve the desired
limit of quantification, hs-CRP assays have been developed
that can reliably measure hs-CRP concentrations as low as
0.15 mg/L (<2.5th percentile of the general population). When
measured with a high-sensitivity assay, CRP levels appear to
have a predictive value for cardiovascular morbidity and mor-
tality. Moreover, baseline levels of CRP predict the risk of
future myocardial infarction, stroke, and peripheral atheroscle-
rosis, even after adjustment for other known cardiovascular
risk factors (10). We employed this method in the present
study, and we found that obese children had significantly
higher hs-CRP levels than control subjects. Further studies
will be required to determine cut-off values for hs-CRP in
obese children. 
High-resolution ultrasound is a reliable, noninvasive method
for detecting early structural and functional atherosclerotic
changes in the arterial wall. Increased carotid IMT is a struc-
tural marker of early atherosclerosis that correlates with vas-
cular risk factors and is related to the severity and extent of
coronary artery disease. FMD of the brachial artery is a marker
of endothelial function that can be assessed by measuring arte-
rial diameter responses to increased flow (11). Brachial artery
FMD occurs mainly as the result of endothelial release of nitric
oxide and correlates with coronary endothelial function (12).
Both increased IMT and impaired FMD have been detected
in young children who have risk factors for atherosclerosis
such as familial hypercholesterolemia (13) and diabetes (14).
In the present study, obese children were also found to have
increased IMT and impaired FMD compared to the healthy
controls. In addition, IMT was positively correlated with
BMI, SBP, and DBP, and negatively correlated with HDL-C
concentrations. Zhu et al. reported a similar result in 43
obese children (15), and Kim et al. showed that IMT corre-
lated with DBP and homocysteine concentrations (16). 
Woo et al. have confirmed that the degree of endothelial
dysfunction correlated with BMI as assessed by multivariate
analysis (17). In the current study, FMD was shown to cor-
relate with BMI, SBP, and TG and Apo E concentrations. 
Traditional risk factors for cardiovascular disease include
aging, hypertension, dyslipidemia, smoking, and diabetes.
The contribution of lipid accumulation to atherosclerotic
disease is well known, but laboratory and experimental evi-
dence indicates that chronic inflammatory processes also play
an important role in the development of atherosclerosis (18).
In order to effectively prevent the incidence of cardiovascu-
lar events, it is important to weigh the influence of each risk
factor on the cardiovascular system. In addition, it should
be borne in mind that various cardiovascular factors are not
independent of one another but often have direct or indirect
interactions (19). In this respect, we investigated the relation-
ship of inflammatory markers with other risk factors. Elevat-
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Fig. 1. Linear correlation of high-sensitivity C-reative protein (hs-
CRP) and flow-mediated dilation (FMD) in the obesity group (r=
-0.327, p<0.05, hs-CRP=6.472-1.89*FMD).
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Fig. 2. Linear correlation of high-sensitivity C-reative protein (hs-
CRP) and intima-media thickness (IMT) in the obesity group (r=
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ed serum CRP levels were positively associated with elevat-
ed BMI, confirming previous observations in both children
(19) and adults (20). The mechanisms underlying this asso-
ciation with BMI or obesity might be as follows; the adipose
tissue is a source of cytokines such as tumor necrosis factor-a
(TNF-a) and interleukin-6 (IL-6), and these cytokines stim-
ulate the production of acute-phase proteins such as C-reac-
tive protein in the liver (21). Not unexpectedly, then, we
found that serum CRP levels were positively associated with
BMI. Because we have not checked proinflammatory cyto-
kines such as TNF-a and IL-6, we can not verify the eleva-
tion of these cytokines as a consequence of obesity.
In addition to BMI, CRP was also found to be closely cor-
related with SBP, DBP, and ApoE and TG concentrations.
Previous studies reported that CRP levels are significantly
positively correlated with TG, total ratio of serum cholesterol
to serum HDL cholesterol (22), fibrinogen levels, heart rate,
SBP (19), smoking, and white blood cell count (5) and neg-
atively correlated with HDL-C levels (19, 22). Several stud-
ies have examined the relationship between CRP and carotid
IMT in adults. Hak et al. found a highly significant relation-
ship between markers of obesity and CRP in healthy, mid-
dle-aged women, but failed to find a significant relationship
between CRP and subclinical atherosclerosis of the carotid
system (20). Sitzer et al. performed a large scale study that
showed the serum CRP level is linearly positively correlated
with IMT in apparently healthy adults (3). Hayaishi et al.
reported that the hs-CRP level is positively associated with
carotid IMT in young patients with type 1 diabetes (23).
Several studies have also shown an association between ele-
vated CRP concentrations and endothelial dysfunction in
adult patients with coronary artery disease (24) and with type
2 diabetes (25). In contrast to the significant amount of data
that has accumulated from adult individual, limited data exists
concerning CRP and subclinical atherosclerosis in children.
Jarvisalo et al. reported that, in healthy children, elevated
serum CRP levels were significantly associated with decreased
endothelial vasodilatory function and increased IMT (26).
Our results are consistent with the Mangge’s report (27) that
serum hs-CRP correlated positively with IMT and inversely
with FMD in the obesity group. In other words, if hs-CRP
is increased in asymptomatic obese children, we can assume
the existence of and advanced subclinical atherosclerosis, in-
creased IMT, and decreased endothelial vasodilatory function
without performing an ultrasound.
In summary, we found a highly significant correlation bet-
ween the serum CRP concentration and the early stage of
atherosclerosis in obese children. Although ultrasonography
allows visualization of early subclinical stages of atherosclero-
sis in obese children, the measurement of the serum hs-CRP
level is simpler and cheaper than ultrasonography, is highly
reproducible, and well correlates with IMT and FMD in obese
children. Thus, hs-CRP would be a useful screening marker
for evaluating and estimating the degree of atherosclerosis
in children.
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